A Clinical Comparison of Proclear® 1 Day Multifocal and Clariti® 1 Day Multifocal 3 Add

A Clinical Comparison of Two Soft Multifocal Contact Lenses - Proclear® 1 Day Multifocal and Clariti® 1 Day Multifocal 3 Add

The aim of this study is to compare the overall lens satisfaction between two soft multifocal contact lenses.

Study Overview

Detailed Description

The aim of the study is to evaluate the overall lens satisfaction between two soft multifocal contact lenses when compared to each other after 15 minutes of daily wear each.

Study Type

Interventional

Enrollment (Actual)

67

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • Berkeley, California, United States, 94720
        • University of California, Berkeley, CA

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. They are at least 18 years of age.
  2. They understand their rights as a research subject and are willing and able to sign a Statement of Informed Consent.
  3. They habitually use soft contact lenses (multifocal soft contact lenses, sphere lenses for monovision, sphere lenses for distance vision correction and spectacles for near vision correction,) and have done so for at least the past three months.
  4. They have a minimum reading add of +0.75DS (based on their spectacle refraction)
  5. They have spherical equivalent refractive error between +6.00 to -10.00DS at the corneal plane and refractive astigmatism of no greater than -0.75DC in each eye.
  6. They are able to achieve distance HCVA of +0.10 logMAR or better in each eye.

Exclusion Criteria:

  1. They have an ocular disorder which would normally contra-indicate contact lens wear.
  2. They have a systemic disorder which would normally contra-indicate contact lens wear.
  3. They are aphakic.
  4. They have had corneal refractive surgery.
  5. They have any corneal distortion resulting from previous hard or rigid lens wear or have keratoconus.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: omafilcon A lenses first, then low ADD power somofilcon A lens
Participants will wear two different types of study contact lenses, in a randomized order of testing for the two study contact lens types.
Participants will be randomized to wear omafilcon A lens for 15 minutes.
Participants will be randomized to wear low ADD power somofilcon A lens for 15 minutes.
Experimental: omafilcon A lenses first, then medium ADD power somofilcon A lens
Participants will wear two different types of study contact lenses, in a randomized order of testing for the two study contact lens types.
Participants will be randomized to wear omafilcon A lens for 15 minutes.
Participants will be randomized to wear medium ADD power somofilcon A lens for 15 minutes.
Experimental: omafilcon A lenses first, then high ADD power somofilcon A lens
Participants will wear two different types of study contact lenses, in a randomized order of testing for the two study contact lens types.
Participants will be randomized to wear omafilcon A lens for 15 minutes.
Participants will be randomized to wear high ADD power somofilcon A lens for 15 minutes.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Overall lens satisfaction
Time Frame: At the end of 15 minutes wear
Overall Impression recorded on a visual analog scale of 0 to 100 where (0=Extremely poor. Unmanageable. Cannot use lenses, 100=Excellent. Highly impressed with these lenses overall.)
At the end of 15 minutes wear

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Meng C Lin, OD, Ph.D, UC Berkeley

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 11, 2025

Primary Completion (Actual)

June 26, 2025

Study Completion (Actual)

June 26, 2025

Study Registration Dates

First Submitted

March 5, 2025

First Submitted That Met QC Criteria

March 5, 2025

First Posted (Actual)

March 11, 2025

Study Record Updates

Last Update Posted (Actual)

April 13, 2026

Last Update Submitted That Met QC Criteria

April 9, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • EX-MKTG-165

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Presbyopia

Clinical Trials on omafilcon A lens

Subscribe